D0191801

N/A

Report date: 2024/12/20 10:42:18

Base Information

Drug NameD0191801
Drug Alias NameOral Insulin (N11005)D0191801 Oral InsulinN11005N-11005D0191801 +[6] 
ClassificationBiologics > Protein drugs
Mechanisms of ActionOrnithine decarboxylase stimulantsPhosphokinases stimulants
TargetsOrnithine decarboxylasePhosphokinases
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesInnopharmax Inc
China Registration ClassN/A

Develop Information

Active CompaniesInnopharmax IncBeijing Hospital, Ministry Of Health
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A